Objective: To compare pseudocholinesterase activities in relation to transaminases, GGT and ALP in liver diseases. Method: A prospective study was conducted at College of Medical Sciences -Teaching Hospital (CMS-TH), from May 2011 to May 2013 with 25 healthy (controls) and 25 diagnosed cases each of carcinoma of liver, cirrhosis of liver, infective hepatitis and obstructive jaundice among both sexes of same age group attending medical outpatient and inpatient departments. Serum pseudocholinesterase and other liver function test parameters were performed with semi -autoanalyzer and Roche Hitachi 902 respectively. Result: Pseudocholinesterase level was significantly decrease in the order of control (mean ± SD = 6865.12 ± 928.41) > obstructive jaundice (mean ± SD = 5539 ± 791.05) > infective hepatitis (mean ± SD = 3800.69 ± 764.17) > cirrhosis of liver (mean ± SD = 1735.16 ± 433.82) > carcinoma of liver (mean ± SD = 1369.48 ± 276.64). The difference in the means was statistically significant (p<0.001). Similarly, aspartate transaminase (AST) (Mean ± SD= 311.48 ± 177.15) and alanine transaminase (ALT) (Mean ± SD = 491.36 ± 308.92) were higher in hepatitis but in carcinoma of liver the AST (Mean ± SD = 292.55 ± 92.85) level was higher than ALT (Mean ± SD = 179.24 ± 70.25). The difference in the means was statistically significant (p<0.001). AST level was 1.6 time higher than ALT. alkaline phosphatase (ALP) (Mean ± SD = 419.39 ± 90.49) and gamma glutamyl transaminase (GGT) (Mean ± SD = 257.81 ± 68.29) level were higher in obstructive jaundice and GGT (Mean ± SD = 195.54 ± 107.75) level was found to be higher in carcinoma of liver. The difference in the means was statistically significant (p<0.001). Conclusion: There was significant decrease in pseudocholinesterase level in carcinoma of liver followed by cirrhosis of liver and less so in infective hepatitis. AST and ALT level were higher in hepatitis cases. The level of AST was found higher in carcinoma of liver than ALT. In obstructive jaundice ALP and GGT was raised and statistically significant. GGT level was raised in carcinoma of liver. Pseudocholinesterase level was found to be normal in obstructive jaundice. The study results indicated that with more severe liver cell destruction or cell degeneration, there was corresponding significant decrease in the level of pseudocholinesterase, which could be used as diagnostic marker of liver disease.
INTRODUCTION
Cholinesterase is defined as an enzyme which hydrolyses acetylcholine and other choline ester at a more rapid rate than non-choline esters (1) . Other esterases occurring in animal tissues were found to be incapable of hydrolyzing acetylcholine (2) . In 1943 Mendel and Rudney classified Cholinesterases (3, 4) . It was divided into two classes according to differing in their substrate specificity, behavior in excess substrate and susceptibility to inhibitors as: acetylcholinesterase and pseudocholinesterase (5, 6) . Pseudocholinesterases (PChE) are also known as butyrylcholinesterase (BChE), serum cholinesterase, false cholinesterase or (most formally) acylcholine acylhydrolase, found in the central and peripheral nervous system, brain, kidney, intestine, pancreas and in the liver (hepatocytes) (7, 8, 9) . It is synthesized in liver and secreted into plasma mainly as a tetrameric glycoprotein (10, 11) . It can hydrolyze hydrophobic and hydrophilic carboxylic or phosphoric acid ester containing compounds (6) . It was so named due to its ability to hydrolyze butyrylcholine faster than other esters (12) . It has a half-life of about 12 days (7, 13, 14, 15, 16) . It's normal value ranges between 5,900 and 13,200 IU/L (20.21) . Physiologically, the function of this enzyme is unknown (6.10.17.18) . But individuals whose BChE is absent does not correlate with any physiological abnormality (6) . Pseudocholinesterase is a non-specific cholinesterase found in the blood plasma and may be reduced in patients with advanced liver disease. The use of the activities of three enzymes alanine aminotransferase (ALT), gamma-glutamyltransferase (GGT), and cholinesterase (ChE) as screening tests for detecting liver disorders were recommended at the annual meeting of the German Society for Internal Medicine in 1975 (19) . A comparative study of pseudocholinesterase along with other relevant liver function test parameters were investigated in different liver disorders like carcinoma of liver, cirrhosis of liver, infective hepatitis and obstructive jaundice to evaluate the prognostic marker for differentiating liver disorders.
MATERIAL AND METHOD
The present prospective study was carried out at College of Medical Sciences-Teaching Hospital, Bharatpur from May 2011 to May 2013. In the present study 25 controls which included the staff and students of both sex between 20 to 70 yrs age. A 25-diagnosed case each comprising carcinoma of liver, cirrhosis of liver, infective hepatitis and obstructive jaundice of both sexes of same age group patient were selected in the present study attending college of medical sciences OPD and IPD suffering from liver diseases. Serum pseudocholinesterase and other liver function tests were performed with semi-autoanalyser and Roche Hitachi 902 respectively in controls and cases. An increased activity of this enzyme has been reported in obesity, diabetes, uremia, hyperthyroidism and hyperlipemic subjects (10, 20, 21) . Low plasma PChE levels have also been found in protein energy malnutrition, during stress and (chronic and acute) inflammation, and in other clinical conditions (22) were excluded from the study. Pseudocholinesterase estimation is done by colorimetric 5,5'-dithiobis-2-nitrobenzoic acid (DNTB) method using AMP diagnostics.
Colorimetric method
Cholinesterase hydrolyses butyrylthiocholine to butyrate and thiocholine. Thiocholine reacts with DNTB to form nitro-2-mercapto-5-benzoate, a yellow compound according to the following reaction. It will be measured at 405 nm. 
Statistical analysis
Statistical analysis was done by SPSS 15. In the Table  1 , the values are shown in mean ± SD. Independent sample T Test was used to compare the means between different groups.
RESULTS
Gender and age wise distribution of cases and controls are shown in Table 1 and 2. In all the disease groups, there was male predominance except in obstructive jaundice. Majority of patients belonged to age group 41 to 60 years. As per table nearly 80% decrease in Pseudocholinesterase in Carcinoma of liver as compared to control, which is highly significant (P<0.001). Similarly, AST is raised more than ALT and GGT and are also highly significant (P<0.001).
AST/ALT ratio also shows significant rise (p<0.001). Similarly, ALP is also significantly more than the control (p <0.001). As per table nearly 30% decreased in Pseudocholinesterase level in obstructive jaundice as compared to control, which is highly significant (P<0.001). The level is normal but lesser than the control. Similarly, GGT is raised more than ALT and AST and are also highly significant (P<0.001). AST/ALT ratio is insignificant (p=0.547). Similarly, ALP is also significantly more than the control (p<0.001). 
DISCUSSION
Pseudocholinesterase level was significantly decrease in the order of control (mean ± SD = 6865.12 ± 928.41) > obstructive jaundice (mean ± SD = 5539 ± 791.05) > infective hepatitis (mean ± SD = 3800.69 ± 764.17) > cirrhosis of liver (mean ± SD = 1735.16 ± 433.82) > carcinoma of liver (mean ± SD = 1369.48 ± 276.64). The decrease in Pseudocholinesterase level was observed in all types of liver diseases i.e. in carcinoma of liver was highest (80%) and in case of cirrhosis of liver (75%) and in infective hepatitis (45%) and in obstructive jaundice (30%) respectively. The difference in the mean was statistically significant as p<0.001 in the Figure 1 . The decreased level obtained was three fourths of the control. The level of pseudocholinesterase was severely decreased in carcinoma of liver than infective hepatitis and cirrhosis of liver. One can infer therefore that, pseudocholinesterase reduces when the functional parenchymal cells are damaged, or decrease as the liver synthesizes pseudocholinesterase. In advanced liver cancer mild to moderate inflammation is frequent and interacts with various degree of protein energy malnutrition. Its levels resulted to be decreased in advanced cancer patients, with or without hepatic involvement. In cirrhosis of liver pseudocholinesterase level would decrease very much when number of functional parenchymal cells of liver decreases. In infective hepatitis the liver cells are damaged but not decreased in hepatocytes as in the case of cirrhosis or carcinoma of liver (23, 24) . Similarly, AST (Mean ± SD= 311.48 ± 177.15) and ALT (Mean ± SD = 491.36 ± 308.92) was increased significantly in hepatitis as p <0.001. But in carcinoma of liver the AST (Mean ± SD = 292.55 ± 92.85) level was higher than ALT (Mean ± SD = 179.24 ± 70.25). The difference in the means was statistically significant (p<0.001). AST level was 1.6 time higher than ALT. The ALP (Mean ± SD = 419.39 ± 90.49) level was significantly increased in obstructive jaundice as p< 0.001 as shown Figure 2 . ALT is an enzyme produced mainly in the liver. When serum activity is measured, it provides a marker of hepatic disease (25) . The liver contains ALT mainly in cytoplasm. Damage to one gram of liver tissue results in a significant increase in the serum ALT activity (26) . But not always ALT is increased in hepatitis. Especially, in hepatitis C virus (HCV) and fatty deposit it remains normal and without giving any information about intra hepatic obstruction. 24 In liver more than 80 % of AST is present in mitochondria and endoplasmic reticulum and damage to one gram of liver tissue results in a significant increase in the serum AST activity especially following liver cell necrosis and destruction. Hence, the increased level of AST found in blood is considered to be a sensitive indicator of liver damage (26, 27) . Zone 3 of the hepatic acinus has a higher concentration of AST, and damage to this zone (28) or especially in the hepatic centrilobular regions which are particularly sensitive to ischemic or toxic, may result in greater alteration to AST levels (27, 28) . The level of pseudocholinesterase was found to be high in obstructive jaundice than other specific liver disorders but was lesser than controls as shown in our Table 1 and Figure 1 . In obstructive jaundice the problem is outside the liver and due to obstruction either in right and left hepatic duct or in gall bladder or in cystic duct or in common bile duct (24) . The liver is the main source of pseudocholinesterase enzyme and hence pseudocholinesterase level was found to be decreased very much in carcinoma of liver followed by cirrhosis of liver and than in infective hepatitis and it was higher in obstructive jaundice than other liver specific disorders. If diagnostic significance of other liver function test parameters were concerned, AST is a non-specific marker of liver cell damage, whereas ALP is a non-specific marker of obstructive jaundice. As still ALP level was found to be more in obstructive jaundice (not a liver cell damage) than cirrhosis of liver (specific liver cell damage and reduction). This could be correlated to the response of liver to any form of biliary tree obstruction induces synthesis of ALP by hepatocytes (22) . Similarly, GGT (Mean ± SD = 257.81 ± 68. were higher in obstructive jaundice and carcinoma of liver respectively. The difference in the means was statistically significant (p<0.001). A rise in level may be due to expression of the surface of shed liver plasma membrane fragments, resulting in raised serum levels of enzymes in various disorders (29) .
CONCLUSION
This study concludes that, Pseudocholinesterase is more specific and better marker of liver disorder and could be used as diagnostic marker.
Pseudocholinesterase, Transaminase, GGT along with ALP, can be used as biochemical markers in differentiating various liver disorders. Pseudocholinesterase concentration decreases correspondingly and specifically with more functional liver cell damage. However, for definitive diagnosis of liver diseases, tissue biopsy has always a greater role in cirrhosis and carcinoma of liver.
